Detalhe da pesquisa
1.
Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
Transfusion
; 62(3): 570-583, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128658
2.
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.
Transfusion
; 61(9): 2677-2687, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121205
3.
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.
Transfusion
; 61(4): 1160-1170, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554362
4.
Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice.
Front Immunol
; 14: 1281123, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090570
5.
Polyinosinic: polycytidylic acid induced inflammation enhances while lipopolysaccharide diminishes alloimmunity to platelet transfusion in mice.
Front Immunol
; 14: 1281130, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146372